A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10–60 Years Following Essen and Zagreb Vaccination Procedures

A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10–60 Years Following Essen and Zagreb Vaccination Procedures

Objective: In this paper, we aim to show that the immunogenicity of the lyophilized human rabies vaccine (Vero cells) (investigational vaccine) developed by Dalian Aleph Biomedical Co., Ltd. in healthy participants aged 10–60 years old is non-inferior to the lyophilized PVRV (positive control) manuf...

Full description

Bibliographic Details
Main Authors: Xiaohong Wu, Jia Li, Lei Zhou, Jianmin Chen, Zhongqiang Jin, Qingwei Meng, Jing Chai, Hongxia Gao, Yunpeng Wang, Danhua Zhao, Heng Wu, Jieran Yu, Nan Chen, Yanan Wang, Yuan Lin, Peifang Huang, Yuhua Li, Yuhui Zhang
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Vaccines
Subjects:
lyophilized human rabies vaccine (Vero cells)
Essen and Zagreb procedures
immunogenicity
safety
non-inferiority
Online Access:https://www.mdpi.com/2076-393X/11/8/1311

Internet

https://www.mdpi.com/2076-393X/11/8/1311

Similar Items